History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
about
BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosisBacille-Calmette-Guerin non-responders: how to manageApplications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyTumor immunotherapy: lessons from autoimmunityBacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccineSynergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumorsCurrent efforts and future prospects in the development of live mycobacteria as vaccinesSystemic, perioperative management of muscle-invasive bladder cancer and future horizons.Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteinsTopical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.Immunotherapy for bladder cancer.Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.Modelling bladder cancer in mice: opportunities and challenges.Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumorDifferential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-AnalysisGecko proteins induce the apoptosis of bladder cancer 5637 cells by inhibiting Akt and activating the intrinsic caspase cascadeLow-dose bacille Calmette-Guérin for non-muscle-invasive bladder cancer: Results of a prospective study.DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignanciesBlocking immune checkpoints in prostate, kidney, and urothelial cancer: An overviewImmunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model.Immunotherapy for urothelial carcinoma: current status and perspectives.Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.Application potential of toll-like receptors in cancer immunotherapy: Systematic review.Effects of Toxoplasma gondii and Toxocara canis antigens on WEHI-164 fibrosarcoma growth in a mouse model.TLR4-mediated immunomodulatory properties of the bacterial metalloprotease arazyme in preclinical tumor modelsA novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF.Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladderImmune infiltration in human tumors: a prognostic factor that should not be ignored.Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG).Investigational therapies for non-muscle invasive bladder cancer.Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune PathwaysMUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer.CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
P2860
Q24604781-6EA98B62-1F31-497A-BC04-12514DDCF0A5Q26773679-7F981D2C-A30A-426D-99DC-DE1A91886D21Q26798372-F662FC5D-CD05-469E-9A5D-EC684D818FC7Q26866179-36D897AB-3A73-40D9-BCBE-3F7EA3522AC5Q27006765-AEE82151-9B7C-4721-AC3F-6801DB5F8635Q27324860-114E6DF3-74C7-4D33-BF71-0B195912D009Q28087077-0765D17B-B250-4B42-BFC3-4111080B1886Q30240816-CF4851C9-9220-4981-B3F8-E2F011AEB284Q33444699-464598CA-9722-4B63-AF43-4F7A17476FC7Q33485621-C3873C95-2AD0-436A-B4DE-AF7CA0F6F244Q33563230-8EA70260-D9D1-4FA3-96B0-7C5E8F7C236AQ33945057-3F184663-7E11-4081-8F55-CF8FEEF49E4EQ33997622-3FD0E178-4AD7-48ED-BA3A-2E272139E336Q34477444-94ECC887-1EC6-4941-888F-CB1F7075C305Q35212274-05F4E20D-8664-4B1B-90AB-2C3082FC161CQ35285703-E87636CD-7D1A-439E-AEB6-931943D5F266Q35372913-CD9B2D44-263F-4E28-B6CF-D49BD6E55257Q35440552-21728C3F-4E8D-494A-87C2-8DEAE7F8A374Q35798992-F8E390CD-CB17-42DC-89DB-C145AB286F99Q36165332-634FB094-843E-4FBB-A539-1FC31967B8C1Q36270006-A83B720D-8701-48F9-9383-4F4B4AB0AF44Q36309607-DDFA26F2-D2E2-468F-ABBC-D81F62980023Q36544893-497E9E16-B43F-4BBB-B1B4-68E032118578Q36806906-27D8232D-390D-4579-A29F-F1BB8388825BQ37109988-61D625CE-E586-4D98-BC0D-1C3D55381A2FQ37137381-374829B9-EBC8-430E-83AE-27C63807AA48Q37198049-B723AD6F-00A0-4BC2-963B-8434D1E601E5Q37205171-F982DAE5-79D0-4E5A-9BAE-E6C377F3026FQ37208397-30CEC3A3-6A9D-45DF-9DE1-B45173776360Q37222202-FB19A6E2-7A81-4DC1-BFC9-E102D819DF52Q37311057-3BF9B96D-B3B2-408C-A385-BC400D1C3AD7Q37635650-0C50824A-6933-4312-859A-3008FA8B379EQ37641059-2D038F55-B58B-48C2-868D-BF40CF603AA3Q37660290-81933F84-ADDD-409D-885B-C098D47D443FQ37672337-E966718D-A64E-4235-891F-2B0A4AA23F51Q37676223-7FF6768C-5F0D-4992-9AC1-DF5D96B1F41FQ37690959-CF055F91-E330-4AFE-A25A-DB9515AFC689Q37737313-234C3D3E-4EEA-44AB-8C94-68B49A5771CFQ37811051-9B6717CD-AB0A-433B-A2ED-5EA829A1364EQ37892578-CEF2184C-FB12-4819-A53E-392DD4FAF5B1
P2860
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
@en
type
label
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
@en
prefLabel
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
@en
P1476
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story.
@en
P2093
Alvaro Morales
Harry W Herr
P356
10.1016/J.JURO.2007.08.122
P407
P577
2007-11-13T00:00:00Z